Consensus-based Recommendations on the Management of Immunosuppression After Squamous Cell Carcinoma Diagnosis in Kidney Transplant Recipients: An International Delphi Consensus Statement.

ABSTRACT:

Background

Posttransplant immunosuppression in kidney transplant recipients is associated with an increased risk of developing cutaneous squamous cell carcinoma (CSCC), contributing to significant morbidity and mortality. Various dermatological and immunosuppression modulation strategies have been identified that may reduce the risk of CSCC, both in primary and secondary prevention settings. Recent recommendations have provided consensus regarding dermatological approaches to prevent CSCC. Comparable transplant nephrology recommendations to guide immunosuppression modulation for CSCC prevention are currently lacking, leading to marked variation in practice.

Methods

To address this knowledge gap, 46 international transplant nephrology experts participated in a 3-round Delphi

SUBMITTER: Whitley MJ 

PROVIDER: S-EPMC12711373 | biostudies-literature | 2026 Jan

REPOSITORIES: biostudies-literature